تقرير
Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
| العنوان: | Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis. |
|---|---|
| المؤلفون: | Blackman A; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Morrison B; Seattle Children's Hospital, Seattle, WA, USA., Maruri F; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA., van der Heijden Y; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; The Aurum Institute, Johannesburg, South Africa., Nochowicz CH; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Guo Y; University of New Mexico, Albuquerque, NM, USA., Scholz M; Vanderbilt Technologies for Advanced Genomics (VANTAGE) Core, Vanderbilt University Medical Center, Nashville, TN, USA., Rustad T; Seattle Children's Hospital, Seattle, WA, USA., Sherman DR; Seattle Children's Hospital, Seattle, WA, USA.; Department of Microbiology, University of Washington, Seattle, WA, USA., Sterling TR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA. |
| المصدر: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Feb 11; Vol. 76 (3), pp. 820-822. |
| نوع المنشور: | Letter; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 1997- : London : Oxford University Press Original Publication: London, New York, Academic Press. |
| مواضيع طبية MeSH: | Bacterial Proteins*/genetics , Mycobacterium tuberculosis*/genetics , Type VII Secretion Systems*/genetics, Drug Resistance, Bacterial/*genetics, Mutation ; Ofloxacin |
| References: | Brief Bioinform. 2014 Nov;15(6):879-89. (PMID: 24067931) J Antimicrob Chemother. 2011 Apr;66(4):827-33. (PMID: 21393176) J Clin Microbiol. 2012 Apr;50(4):1390-6. (PMID: 22189117) Tuberculosis (Edinb). 2008 Nov;88(6):526-44. (PMID: 18439872) J Antimicrob Chemother. 2016 Sep;71(9):2419-27. (PMID: 27261264) PLoS Genet. 2015 May 04;11(5):e1005190. (PMID: 25938982) PLoS One. 2012;7(12):e52059. (PMID: 23284869) Antimicrob Agents Chemother. 2003 Nov;47(11):3616-9. (PMID: 14576129) |
| معلومات مُعتمدة: | K08 AI106420 United States AI NIAID NIH HHS; R01 AI063200 United States AI NIAID NIH HHS; R56 AI118361 United States AI NIAID NIH HHS |
| المشرفين على المادة: | 0 (Bacterial Proteins) 0 (Type VII Secretion Systems) A4P49JAZ9H (Ofloxacin) |
| تواريخ الأحداث: | Date Created: 20201228 Date Completed: 20210705 Latest Revision: 20220531 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC7879138 |
| DOI: | 10.1093/jac/dkaa507 |
| PMID: | 33367727 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1460-2091 |
|---|---|
| DOI: | 10.1093/jac/dkaa507 |